Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Cl.Cu |
| Molecular Weight | 98.999 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Cu+]
InChI
InChIKey=OXBLHERUFWYNTN-UHFFFAOYSA-M
InChI=1S/ClH.Cu/h1H;/q;+1/p-1
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Cu |
| Molecular Weight | 63.546 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Cuprous Sulfide (Cu2S) occurs in nature as the mineral and has very different two-dimensional lattice structures, along with excellent electro-catalysis and high conductivity. Recently published article has shown that nanocomposites incorporated with Cu2S nanoflowers can be used for skin tumor therapy and wound healing.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cu2S nanosheets for ultrashort pulse generation in the near-infrared region. | 2019-03-28 |
|
| Correction to Electrospun Micropatterned Nanocomposites Incorporated with Cu2S Nanoflowers for Skin Tumor Therapy and Wound Healing. | 2019-03-26 |
|
| Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. | 2010-12 |
|
| Copper binding affinity of S100A13, a key component of the FGF-1 nonclassical copper-dependent release complex. | 2006-09-01 |
|
| Synthesis, molecular characterization, and biological activity of novel synthetic derivatives of chromen-4-one in human cancer cells. | 2006-06-29 |
|
| Methionine regulates copper/hydrogen peroxide oxidation products of Abeta. | 2005-06 |
|
| Iron and gallium increase iron uptake from transferrin by human melanoma cells: further examination of the ferric ammonium citrate-activated iron uptake process. | 2001-04-30 |
|
| Human NAD(P)H:quinone oxidoreductase induction in human hepatoma cells after exposure to industrial acrylates, phenolics, and metals. | 1997-02 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:53:55 GMT 2025
by
admin
on
Mon Mar 31 19:53:55 GMT 2025
|
| Record UNII |
C955P95064
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EPA PESTICIDE CODE |
108303
Created by
admin on Mon Mar 31 19:53:55 GMT 2025 , Edited by admin on Mon Mar 31 19:53:55 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
COPPER(I) CHLORIDE
Created by
admin on Mon Mar 31 19:53:55 GMT 2025 , Edited by admin on Mon Mar 31 19:53:55 GMT 2025
|
PRIMARY | |||
|
DB15535
Created by
admin on Mon Mar 31 19:53:55 GMT 2025 , Edited by admin on Mon Mar 31 19:53:55 GMT 2025
|
PRIMARY | |||
|
7758-89-6
Created by
admin on Mon Mar 31 19:53:55 GMT 2025 , Edited by admin on Mon Mar 31 19:53:55 GMT 2025
|
PRIMARY | |||
|
m3920
Created by
admin on Mon Mar 31 19:53:55 GMT 2025 , Edited by admin on Mon Mar 31 19:53:55 GMT 2025
|
PRIMARY | Merck Index | ||
|
C028419
Created by
admin on Mon Mar 31 19:53:55 GMT 2025 , Edited by admin on Mon Mar 31 19:53:55 GMT 2025
|
PRIMARY | |||
|
53472
Created by
admin on Mon Mar 31 19:53:55 GMT 2025 , Edited by admin on Mon Mar 31 19:53:55 GMT 2025
|
PRIMARY | |||
|
231-842-9
Created by
admin on Mon Mar 31 19:53:55 GMT 2025 , Edited by admin on Mon Mar 31 19:53:55 GMT 2025
|
PRIMARY | |||
|
C955P95064
Created by
admin on Mon Mar 31 19:53:55 GMT 2025 , Edited by admin on Mon Mar 31 19:53:55 GMT 2025
|
PRIMARY | |||
|
DTXSID5035242
Created by
admin on Mon Mar 31 19:53:55 GMT 2025 , Edited by admin on Mon Mar 31 19:53:55 GMT 2025
|
PRIMARY | |||
|
C955P95064
Created by
admin on Mon Mar 31 19:53:55 GMT 2025 , Edited by admin on Mon Mar 31 19:53:55 GMT 2025
|
PRIMARY | |||
|
1423796
Created by
admin on Mon Mar 31 19:53:55 GMT 2025 , Edited by admin on Mon Mar 31 19:53:55 GMT 2025
|
PRIMARY | RxNorm | ||
|
62652
Created by
admin on Mon Mar 31 19:53:55 GMT 2025 , Edited by admin on Mon Mar 31 19:53:55 GMT 2025
|
PRIMARY |